Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-23,200
Closed -$1.93M 8100
2018
Q1
$1.93M Buy
+23,200
New +$2.09M ﹤0.01% 3171
2016
Q1
Sell
-700
Closed -$76K 7872
2015
Q4
$76K Hold
700
﹤0.01% 5438
2015
Q3
$77K Hold
700
﹤0.01% 5446
2015
Q2
$73K Hold
700
﹤0.01% 5660
2015
Q1
$64K Sell
700
-2,500
-78% -$207K ﹤0.01% 5811
2014
Q4
$234K Buy
+3,200
New +$209K ﹤0.01% 4890

Other funds holding INCY

UBS Group's INCY Position: Q1 2026 in Review

UBS Group increased its Incyte (INCY) stake by 67% in Q1 2026, buying an estimated $45.7M and bringing the position to 1,138,004 shares worth $107M. The position accounts for 0.02% of the portfolio, ranked #1001.

UBS Group first reported a position in INCY in Q4 2014 and has held it in 46 quarters since. The position peaked at $306M in Q2 2018. 811 funds tracked by Wall St. Rank hold INCY as of Q1 2026.

  • UBS Group held 1,138,004 shares of Incyte worth $107M as of Q1 2026.
  • UBS Group bought 457,921 Incyte shares in Q1 2026, an estimated $45.7M.
  • Incyte made up 0.02% of UBS Group's portfolio in Q1 2026, its #1001 holding.
  • UBS Group first reported a position in Incyte in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Incyte position peaked at $306M in Q2 2018.
  • 811 funds tracked by Wall St. Rank held Incyte as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.